Google reveals huge plans to fight Parkinson’s

Advances

Author: Geoffrey ChangPublished: 3 September 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Google-contact-lens

Google is pumping money into its innovative life sciences plans that will benefit Parkinson’s patients

Tech giant Google has announced plans to fund a new specialised health division within the company that will focus solely on making advances in the treatment of long-term conditions.

Some 10 million people living with Parkinson’s around the world – as well as those suffering from cancer, diabetes and heart disease – could benefit from the move, which experts predict will lead to a new wave of healthcare product development.

Google’s new life sciences team will “develop new technologies to make healthcare more proactive,” according to a statement put out by the company.

The overall mission to increase life span via this healthcare drive is seen by Google’s top bosses as part of their social responsibility, while supplying the technology to help patients in these areas is considered to be a huge potential commercial opportunity in the long-term.

Though the move shows Google’s intention to be at the forefront of the lucrative health tech market, for Sergey Brin – co-founder of Google – the reasons are also personal since his mother developed Parkinson’s.

In a recent Google+ post, Brin revealed how the new health unit stems from the company’s work on smart contact lenses, describing the process as “an immensely challenging technical problem with an important application to health.”

Brin added: “I could not have imagined the potential of the initiative it has grown into – a life sciences team with the mission to develop new technologies to make healthcare more proactive.”

Go Back

Share this story

Comments


Related articles


Special reports

Investigating rhythm, dance and Parkinson’s disease

Dr Psyche Loui tells us about “dance intervention”

READ MORE
OraFuse-lead

Advances

83-year-old invents Parkinson’s ‘retainer’ to deliver oral levodopa via the mouth

New device delivers oral levodopa at continuous, controlled rate

READ MORE
Prof Timmermann

sponsored article

Advances

Personalised and on-the-spot therapy: deep brain stimulation

Boston Scientific’s Vercise deep brain stimulation system

READ MORE